Because BACE1 is the principal secretase, scientists created transgenic mouse models with overexpression of human APP with known familial AD mutations and a germline gene deletion of BACE1 to test the effect of deletion on ABP generation in mice prone to developing AD. The gene discussed is BACE1; the disease is Alzheimer disease.